A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Primary Purpose
Male Circumcision, HIV Prevention, HIV Infections
Status
Completed
Phase
Not Applicable
Locations
Rwanda
Study Type
Interventional
Intervention
The PrePex a novel device for adult male circumcision
Sponsored by
About this trial
This is an interventional prevention trial for Male Circumcision focused on measuring male circumcision, HIV, Rwanda, HIV Seronegativity
Eligibility Criteria
Inclusion Criteria:
- Male of ages 18 - 54 years
- Subject wants to be circumcised
- Uncircumcised
- HIV sero-negative Agrees to undergo measurements of width of the penis at different areas in flaccid status
- Able to understand the study procedures and requirements
- Agrees to abstain sexual intercourse and to keep caution not directly rub the cut area if masturbating, until the end of the follow-up that may take up to 6 weeks
- Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
Exclusion Criteria:
- Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
- HIV sero-positive
- Subject with the following diseases: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias
- Diabetes mellitus
- Subject who have an abnormal penile anatomy or any penile diseases
- Subject that to the opinion of the investigator is not a good candidate
Sites / Locations
- Kanombe Military Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Males undergoing circumcision
Arm Description
Outcomes
Primary Outcome Measures
The efficacy and safety of The PrePex System for adult male circumcision in Rwanda
Outcome measures will include:
Number of Participants with Adverse Events as a Measure of Safety,
Pain as measured by Visual Analogue Scale (VAS),
Wound healing rate.
Secondary Outcome Measures
Operational scalability to mass scale up program
Outome measure include:
Duration required by diffrent personnel to perform the procedure Procedure performance by nurses
satisfaction & acceptability of patients
Outcome measure include:
Quality of life and satisfaction questionnaire
Guidelines for utility in scale up mass circumcision program
Outcome measure includes:
Physicians questionnaire on the clinical and practical performance of the procedure
compliance with post procedure instructions
Outcome measure include:
Weekly follow up visits post procedure, compliance with post procedure instructions questionnaire
Full Information
NCT ID
NCT01150370
First Posted
June 23, 2010
Last Updated
January 10, 2011
Sponsor
Ministry of Health, Rwanda
Collaborators
Ministry of Defence, Rwanda
1. Study Identification
Unique Protocol Identification Number
NCT01150370
Brief Title
A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Official Title
A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Study Type
Interventional
2. Study Status
Record Verification Date
December 2010
Overall Recruitment Status
Completed
Study Start Date
June 2010 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
December 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Ministry of Health, Rwanda
Collaborators
Ministry of Defence, Rwanda
4. Oversight
5. Study Description
Brief Summary
The protocol, approved by the Rwanda National Ethical Committee, was issued to assess the safety and efficacy of the circumcision device for applying it to the national scale up of adult male circumcision in Rwanda
Detailed Description
Multiple randomized and controlled studies (WHO, USAID, UNAIDS) have proven that circumcised men in high risk areas reduce their risk of HIV infection by 60%.
The Government of Rwanda has ranked HIV prevention as a top priority item, and wishes to decrease the HIV incidence in the country by 50%. As part of a holistic HIV prevention approach, we decided to embark upon a process of national scale up of adult male circumcision. The national HIV prevention plan calls for voluntary MC of 2 million adults by the end of 2012.
The PrePex System was designed to enable safe, effective, painless and bloodless male circumcision programs, to support global public health efforts to stop the spread of HIV.
The PrePex System includes a simple, disposable device that is easy to use and can be deployed by minimally trained healthcare professionals, in urban or rural settings, without the need for sterile, hospital settings. As such, The PrePex System places minimal burden on the existing health care infrastructure to accomplish national circumcision programs.
The protocol, approved by the Rwanda National Ethical Committee, was issued to assess the safety and efficacy of the circumcision device for applying it to the national scale up of adult male circumcision in Rwanda.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Male Circumcision, HIV Prevention, HIV Infections
Keywords
male circumcision, HIV, Rwanda, HIV Seronegativity
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Males undergoing circumcision
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
The PrePex a novel device for adult male circumcision
Intervention Description
The PrePex System was designed to enable safe, effective, painless and bloodless male circumcision programs. The PrePex System includes a simple, disposable device that is easy to use and can be deployed by minimally trained healthcare professionals, without the need for sterile, hospital settings.
Primary Outcome Measure Information:
Title
The efficacy and safety of The PrePex System for adult male circumcision in Rwanda
Description
Outcome measures will include:
Number of Participants with Adverse Events as a Measure of Safety,
Pain as measured by Visual Analogue Scale (VAS),
Wound healing rate.
Time Frame
4 week post-procedure follow up appointment and examination
Secondary Outcome Measure Information:
Title
Operational scalability to mass scale up program
Description
Outome measure include:
Duration required by diffrent personnel to perform the procedure Procedure performance by nurses
Time Frame
four week post-procedure follow up appointment and examination
Title
satisfaction & acceptability of patients
Description
Outcome measure include:
Quality of life and satisfaction questionnaire
Time Frame
4 weeks follow up
Title
Guidelines for utility in scale up mass circumcision program
Description
Outcome measure includes:
Physicians questionnaire on the clinical and practical performance of the procedure
Time Frame
4 weeks follow up
Title
compliance with post procedure instructions
Description
Outcome measure include:
Weekly follow up visits post procedure, compliance with post procedure instructions questionnaire
Time Frame
4 weeks follow up
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
54 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male of ages 18 - 54 years
Subject wants to be circumcised
Uncircumcised
HIV sero-negative Agrees to undergo measurements of width of the penis at different areas in flaccid status
Able to understand the study procedures and requirements
Agrees to abstain sexual intercourse and to keep caution not directly rub the cut area if masturbating, until the end of the follow-up that may take up to 6 weeks
Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
Exclusion Criteria:
Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
HIV sero-positive
Subject with the following diseases: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias
Diabetes mellitus
Subject who have an abnormal penile anatomy or any penile diseases
Subject that to the opinion of the investigator is not a good candidate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr. Jean Paul Bitega, M.D.
Organizational Affiliation
Kanombe Military Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kanombe Military Hospital
City
Kigali
ZIP/Postal Code
3377
Country
Rwanda
12. IPD Sharing Statement
Links:
URL
http://www.moh.gov.rw
Description
Related Info
Learn more about this trial
A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
We'll reach out to this number within 24 hrs